Clinical Characteristics Matrix of Lung Tumor Under Stereotactic Ablative Body Radiotherapy (SABR)

被引：0
|
作者：
Li, K. [1 ]
Jung, E. [2 ]
Wu, B. [3 ]
Mousli, A. [4 ]
Aoki, S. [5 ]
Newton, J. [2 ]
Able, A. [6 ]
Cornell, D. [2 ]
Lee, N. [7 ]
Lo, S. [8 ]
机构：
[1] Associates Med Phys, John R Marsh Canc Ctr, Hagerstown, MD USA
[2] John R Marsh Canc Ctr, Radiat Oncol, Hagerstown, MD USA
[3] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA
[4] St Elisabeth, Radiat Oncol, Pl Louise Godin, Namur, Belgium
[5] Univ Tokyo Hosp, Dept Radiol, Tokyo, Japan
[6] Associates Med Phys, Radiat Oncol, Lanham, MD USA
[7] Georgetown Univ, Georgetown, Guyana
[8] Univ Washington, Med Ctr, Radiat Oncol Ctr, Seattle, WA 98195 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Characteristic Matrix; Stereotactic ablative radiotherapy; Similarity Matching;
D O I：
10.1016/j.jtho.2017.09.1781
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.14-008
引用
收藏
页码：S2333 / S2333
页数：1
相关论文
共 50 条
  • [1] Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
    Goldsmith, Christy
    Gaya, Andrew
    [J]. CANCER IMAGING, 2012, 12 (02): : 351 - 360
  • [2] A national program for the implementation of lung Stereotactic Ablative Body Radiotherapy (SABR)
    Diez, P.
    Haridass, A.
    Lilley, J.
    Patel, R.
    Miles, E.
    Tree, A.
    Clark, C.
    Dean, C.
    Fell, K.
    McDonald, F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S868 - S870
  • [3] Stereotactic ablative body radiotherapy (SABR) for multiple lung tumours: hazardous or harmless?
    Allos, B.
    Carruthers, H.
    Harrop, V.
    Stange, D.
    Misheva, T.
    Stevenson, R.
    Watkins, S.
    Ghafoor, Q.
    [J]. LUNG CANCER, 2018, 115 : S58 - S58
  • [4] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
    Desai, Neil B.
    Laine, Aaron M.
    Timmerman, Robert D.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
  • [5] A case for development of stereotactic ablative body radiotherapy (SABR) for lung cancer at Aberdeen
    Stilwell, C.
    Steven, E.
    Sharma, R. N.
    Bissett, D.
    Shrimali, R. K.
    [J]. LUNG CANCER, 2013, 79 : S58 - S59
  • [6] Clinical implementation of stereotactic ablative radiotherapy (SABR) for lung early stage NSCLC
    Routsis, D.
    Dean, J.
    Archer, S.
    Ferriera, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S304 - S304
  • [7] Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment
    Geng-Cahuayme, Abraham Andre Arturo
    Peregrin-Pastor, Blanca
    Ramos-Albiac, Monica
    Recalde-Vizcay, Enar
    Parada-Zuluaga, Juan Sebastian
    de Sagredo, Jordi Giralt-Lopez
    Maldonado-Pijoan, Xavier
    Giraldo-Marin, Alexandra
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [8] Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
    Groves, Jonathan
    Yeo, Ryan
    Tsang, Yat
    Shah, Nihal
    Win, Thida
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [9] The Future of Stereotactic Ablative Radiotherapy (SABR)
    Loo, B.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S283 - S284
  • [10] Clinical implementation of stereotactic ablative radiotherapy (SABR) for NSCLC in the UK
    Baker, A.
    Clark, C.
    Ciurlionis, L.
    Distefano, G.
    Hatton, M.
    Jain, P.
    Lilley, J.
    Mayles, H.
    Miles, E.
    Scott, A.
    Webster, G.
    [J]. LUNG CANCER, 2013, 79 : S61 - S61
12345